Breast tumours arising in carriers of BRCA1 or BRCA2 mutations, however, also differ from one another and from sporadic tumours in terms of their pathological characteristics, including those assessed morphologically or by immunohistochemistry [8-12]. This evidence concerns the gene BRCA1 and neoplasm.